Primary record
Butanamide, N-((7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-2-oxo-, (6R-(6alpha,7beta,9alpha,14abeta,15alpha))-
- 库存
- 3,375 克
- 纯度
- 98.9 %
- CAS
- 107140-33-0
化合物标识与属性
- CAS
- 107140-33-0
- PubChem CID
- 3086521
- SMILES
- CCC(=O)C(=O)NCC1C2=C(CC3N1C(C4CC5=C(C3N4C)C(=O)C(=C(C5=O)C)OC)C#N)C(=O)C(=C(C2=O)OC)C
- Canonical SMILES
- CCC(=O)C(=O)NCC1C2=C(CC3C4C5=C(CC(C(C#N)N13)N4C)C(=O)C(C)=C(OC)C5=O)C(=O)C(C)=C(OC)C2=O
名称与同义词
- Saframycin Ad-1
- Saframycin-Ad-1
- AC1MJ6CD
- RefChem:180811
- SCHEMBL29884705
- DTXSID10910242
- C30-H32-N4-O8
- CID3086521
- 107140-33-0
- 2,2'-(ethane-1,2-diylbis(oxy))bis(4-fluoroaniline)
- 2-Thiazolamine, 4-(2,3-dihydro-2-methyl-5-benzofuranyl)-
- Butanamide, N-((7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-2-oxo-, (6R-(6alpha,7beta,9alpha,14abeta,15alpha))-
- N-[(12-cyano-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),17-tetraen-10-yl)methyl]-2-oxobutanamide
- 107140-71-6
- 107140-87-4
- N-[(7-Cyano-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-1,5,6,7,9,10,13,14,14a,15-decahydro-4H-6,15-epiminoisoquinolino[3,2-b][3]benzazocin-9-yl)methyl]-2-oxobutanamide